Form 4 for HAE HAEMONETICS CORP
Accepted 2021-08-25 00:00:00 ET · period of report 2021-08-23 · accession 0000899243-21-034143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-25 | 2021-08-23 | HAE | Burke William P. Mr. | EVP, CFO | M - OptEx | $37.96 | +22.7K | 41.5K | +120% | +$860.4K |
| D | 2021-08-25 | 2021-08-23 | HAE | Burke William P. Mr. | EVP, CFO | S - Sale+OE | $60.51 | -22.7K | 30.3K | -43% | -$1.37M |
| DM | 2021-08-25 | 2021-08-23 | HAE | Burke William P. Mr. | EVP, CFO | M - OptEx | $0.00 | -22.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | M | A | 11,435 | $41.64 | 52,958 | D | — | — | (F3) This number includes unvested RSUs previously reported. |
| 2 | Common | Common Stock | 2021-08-23 | M | A | 11,232 | $34.21 | 41,523 | D | — | — | (F3) This number includes unvested RSUs previously reported. |
| 3 | Common | Common Stock | 2021-08-23 | S | D | 22,667 | $60.51 | 30,291 | D | — | — | (F2) Represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $60.06 to $60.88, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. (F3) This number includes unvested RSUs previously reported. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-08-23 | M | D | 11,435 | $0.00 | 0 | D | $41.64 · 2021-06-06 to 2024-06-06 | 11,435 Common Stock | |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-08-23 | M | D | 11,232 | $0.00 | 0 | D | $34.21 · 2020-10-25 to 2023-10-25 | 11,232 Common Stock |